Skip to content

A Standardized Meditation Technique Body-scan, in the Management of Anxiety in Hospitalized Parkinsonian Patients

An Exploratory Study of the Feasibility of the Installation by a Paramedical Staff of a Standardized Meditation Technique Body-scan, in the Management of Anxiety in Hospitalized Parkinsonian Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03349554
Acronym
PARAM2A
Enrollment
33
Registered
2017-11-21
Start date
2018-03-23
Completion date
2019-03-05
Last updated
2019-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, anxiety, meditation, in-patients

Brief summary

The aim of the study is to constitute a proof of concept study for a larger study investigating the effect of mindfulness on anxiety and agitation in Parkinson's disease (PD) based on the results of a preliminary feasibility.

Detailed description

Neuropsychiatric and behavioral non motor symptoms are common in PD often requiring hospitalization and/or specific drug management. Mindfulness-based stress reduction (MBSR) programs have proved to be efficacious in PD both for the management of motor and non-motor symptoms. This is however the case only in out-patients and by using standardized 8 weeks programs. The team has experienced in the hospitalization unit that methods derived from the MBSR program such as the body scan, administered by the paramedical personnel, is of great help for the non-pharmacological management of anxiety and agitation in PD, avoiding physical contention in many cases. Based on this experience the study aims at evaluating the feasibility and preliminary efficacy of a simple and standardized administration of the body scan meditation in the management of anxiety and agitation in PD admitted in the unit since less than 48h.

Interventions

15 minutes audio-guided body-scan meditation

NPI (Neuropsychiatric symptoms Inventory) - PAS (Parkinson's disease Anxiety Screening Questionnaire) - VAS measuring pain, anxiety and discomfort Before and after body-scan meditation

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease * Age over 18 * Admitted in the unit since less than 3 days * Presenting at least 3 symptoms with a severity rated \> 2 at the Hamilton anxiety scale (HAM-A) * Patients with social security insurance * Informed consent signed

Exclusion criteria

* Dementia, delusions or hallucination not permitting an informed consent or necessitating immediate and urgent sedation * Patient under law protection * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Percentage of patients that received a first experience of standardized body scan meditation within 48H after admission48 hours after admission

Secondary

MeasureTime frameDescription
Rate of study drop-outthrough study completion, an average of 1 year
Causes of study drop-outsthrough study completion, an average of 1 yearby oral questionnaire
Mean delay between admission and first meditationAfter body scan meditation, an average of 48 hours after admission
Rate of patient's eligibility and causes of non-eligibilityAt inclusion (day 0)
Percentage of improvement pain, anxiety and discomfortbefore and after body scan meditation, an average of 48 hours after admissionby visual analog scales (VAS)
Percentage of improvement at the Parkinson's diseasebefore and after body scan meditation, an average of 48 hours after admissionby Anxiety Screening Questionnaire (PAS)
Cause of failure of meditation administration within 48h48 hours after admission (day 0)Failure factors: related to staffing (insufficient, untrained...), related to the organization of the service (double room / individual), related to the patient (visits, temporary refusal), related to the equipment (unavailable, non-functional)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026